![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 21, 19229-19235, May 24, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
,
From the Department of Biological Chemistry, Johns Hopkins
University School of Medicine, Baltimore, Maryland 21205-2185
Previously, we reported that c-Myc is
glycosylated by O-linked N-acetylglucosamine at
Thr-58, a known phosphorylation site and a mutational hot spot in
lymphomas. In this paper, we describe the production and
characterization of two Thr-58 site-specific antibodies and use them to
examine the modification of Thr-58 in living cells. One antibody
specifically reacts with the Thr-58-glycosylated form of c-Myc, and the
other reacts only with unmodified Thr-58 in c-Myc. Using these
antibodies together with a commercial anti-Thr-58-phosphorylated c-Myc
antibody, we simultaneously detected three forms of c-Myc (Thr-58-unmodified, -phosphorylated, and -glycosylated). It has been
reported that Thr-58 phosphorylation is dependent on a prior phosphorylation of Ser-62. Mutagenesis of Ser-62 to Ala showed a marked
decrease of Thr-58 phosphorylation and a marked increase of Thr-58
glycosylation. Growth inhibition of HL60 cells by serum starvation
increases Thr-58 glycosylation and correspondingly decreases its
phosphorylation. Serum stimulation has the opposite effect upon the
modification status of Thr-58. A candidate kinase responsible for
Thr-58 phosphorylation is the glycogen synthase kinase 3 (GSK3).
Lithium, a competitive inhibitor of GSK3, decreased Thr-58
phosphorylation and increased its glycosylation. Finally, we show that
the Thr-58-phosphorylated form of c-Myc predominantly accumulates in
the cytoplasm rather than the nucleus upon inhibition of proteasome
activity. These data suggest that hierarchical phosphorylation of
Ser-62 and Thr-58 and alternative glycosylation/phosphorylation of
Thr-58 together regulate the myriad functions of c-Myc in cells.
Fellow of Japan Society for Promotion of Science
Postdoctoral Fellowships for Research Abroad 2000.
§
Present address: University of California at San Diego,
CMM-East, Rm. 1088, 9500 Gilman Dr., La Jolla, CA
92093-0687.
¶
Present address: Laboratory of Cellular and Molecular Biology,
NCI, National Institutes of Health, 37 Convent Dr., MSC 4255, Bldg. 37, Rm. 1C08, Bethesda, MD 20892-4255.
To whom correspondence should be addressed: Dept. of
Biological Chemistry, Johns Hopkins University School of Medicine, 725 N. Wolfe St., Baltimore, MD 21205-2185. Tel.: 410-614-5993; Fax: 410-614-8804; E-mail: gwhart@jhmi.edu.
This article has been cited by other articles:
![]() |
R. J. Copeland, J. W. Bullen, and G. W. Hart Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E17 - E28. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. D. Cheung and G. W. Hart AMP-activated Protein Kinase and p38 MAPK Activate O-GlcNAcylation of Neuronal Proteins during Glucose Deprivation J. Biol. Chem., May 9, 2008; 283(19): 13009 - 13020. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, A. J. Paterson, P. Huang, K. Wang, and J. E. Kudlow Metabolic Control of Proteasome Function Physiology, December 1, 2007; 22(6): 373 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Andrali, Q. Qian, and S. Ozcan Glucose Mediates the Translocation of NeuroD1 by O-Linked Glycosylation J. Biol. Chem., May 25, 2007; 282(21): 15589 - 15596. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Lazarus, D. C. Love, and J. A. Hanover Recombinant O-GlcNAc transferase isoforms: identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates Glycobiology, May 1, 2006; 16(5): 415 - 421. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Sundberg, G. M. Ney, C. Subramanian, A. W. Opipari Jr., and G. D. Glick The Immunomodulatory Benzodiazepine Bz-423 Inhibits B-Cell Proliferation by Targeting c-Myc Protein for Rapid and Specific Degradation Cancer Res., February 1, 2006; 66(3): 1775 - 1782. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ahmad, D. C. Hoessli, E. Walker-Nasir, S. M. Rafik, A. R. Shakoori, and Nasir-ud-Din Oct-2 DNA binding transcription factor: functional consequences of phosphorylation and glycosylation Nucleic Acids Res., January 8, 2006; 34(1): 175 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Buse Hexosamines, insulin resistance, and the complications of diabetes: current status Am J Physiol Endocrinol Metab, January 1, 2006; 290(1): E1 - E8. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Lazarus, M. D. Roos, and J. A. Hanover Mutational Analysis of the Catalytic Domain of O-Linked N-Acetylglucosaminyl Transferase J. Biol. Chem., October 21, 2005; 280(42): 35537 - 35544. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Ludemann, A. Clement, V. H. Hans, J. Leschik, C. Behl, and R. Brandt O-Glycosylation of the Tail Domain of Neurofilament Protein M in Human Neurons and in Spinal Cord Tissue of a Rat Model of Amyotrophic Lateral Sclerosis (ALS) J. Biol. Chem., September 9, 2005; 280(36): 31648 - 31658. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Robertson, L. Li, S. Fisher, V. P. Pearce, J. W. Shay, W. E. Wright, H. D. Cavanagh, and J. V. Jester Characterization of Growth and Differentiation in a Telomerase-Immortalized Human Corneal Epithelial Cell Line Invest. Ophthalmol. Vis. Sci., February 1, 2005; 46(2): 470 - 478. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. E. Zachara, N. O'Donnell, W. D. Cheung, J. J. Mercer, J. D. Marth, and G. W. Hart Dynamic O-GlcNAc Modification of Nucleocytoplasmic Proteins in Response to Stress: A SURVIVAL RESPONSE OF MAMMALIAN CELLS J. Biol. Chem., July 16, 2004; 279(29): 30133 - 30142. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Parker, R. Taylor, D. Jones, and D. McClain Hyperglycemia and Inhibition of Glycogen Synthase in Streptozotocin-treated Mice: ROLE OF O-LINKED N-ACETYLGLUCOSAMINE J. Biol. Chem., May 14, 2004; 279(20): 20636 - 20642. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. O'Donnell, N. E. Zachara, G. W. Hart, and J. D. Marth Ogt-Dependent X-Chromosome-Linked Protein Glycosylation Is a Requisite Modification in Somatic Cell Function and Embryo Viability Mol. Cell. Biol., February 15, 2004; 24(4): 1680 - 1690. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, J. Gildersleeve, Y.-Y. Yang, R. Xu, J. A. Loo, S. Uryu, C.-H. Wong, and P. G. Schultz A New Strategy for the Synthesis of Glycoproteins Science, January 16, 2004; 303(5656): 371 - 373. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Whelan and G. W. Hart Proteomic Approaches to Analyze the Dynamic Relationships Between Nucleocytoplasmic Protein Glycosylation and Phosphorylation Circ. Res., November 28, 2003; 93(11): 1047 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Hatsell, L. Medina, J. Merola, R. Haltiwanger, and P. Cowin Plakoglobin Is O-Glycosylated Close to the N-terminal Destruction Box J. Biol. Chem., September 26, 2003; 278(39): 37745 - 37752. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hiromura, C. H. Choi, N. A. Sabourin, H. Jones, D. Bachvarov, and A. Usheva YY1 Is Regulated by O-Linked N-Acetylglucosaminylation (O-GlcNAcylation) J. Biol. Chem., April 11, 2003; 278(16): 14046 - 14052. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Glass, C. Q. Zeng, and M. K. Estes Two Nonoverlapping Domains on the Norwalk Virus Open Reading Frame 3 (ORF3) Protein Are Involved in the Formation of the Phosphorylated 35K Protein and in ORF3-Capsid Protein Interactions J. Virol., March 15, 2003; 77(6): 3569 - 3577. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Wells, K. Vosseller, R. N. Cole, J. M. Cronshaw, M. J. Matunis, and G. W. Hart Mapping Sites of O-GlcNAc Modification Using Affinity Tags for Serine and Threonine Post-translational Modifications Mol. Cell. Proteomics, October 1, 2002; 1(10): 791 - 804. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |